Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1686196 | 0.97 | TSHR (0.47) | KDM4EPMP22ATMCYP3A4SLC5A7 | |
| Hydrochloric Acid SCHEMBL715477 | 0.93 | KDM4E (0.50) | KDM4EPMP22ATMCYP3A4SLC5A7 | |
| SCHEMBL10002125 | 0.93 | TSHR (0.44) | KDM4EPMP22ATMCYP3A4SLC5A7 | |
| Water SCHEMBL3304873 | 0.93 | TSHR (0.44) | KDM4EPMP22ATMCYP3A4SLC5A7 | |
| Hydrochloric Acid SCHEMBL853896 | 0.93 | KDM4E (0.50) | KDM4EPMP22ATMCYP3A4SLC5A7 | |
| Hydrochloric Acid SCHEMBL8694682 | 0.91 | SLC22A1 (0.47) | KDM4EPMP22ATMCYP3A4SLC5A7 | |
| SCHEMBL476985 | 0.90 | TSHR (0.47) | KDM4EPMP22ATMCYP3A4SLC5A7 | |
| SCHEMBL1686254 | 0.90 | TSHR (0.47) | KDM4EPMP22ATMCYP3A4SLC5A7 | |
| SCHEMBL10002123 | 0.88 | DNM1 (0.50) | CYP3A4TSHRDNM1SLC22A1 | |
| SCHEMBL28465064 | 0.88 | SLC22A1 (0.50) | KDM4EPMP22ATMCYP3A4SLC5A7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107922205-B | Method for producing AEI-type zeolite | 东曹株式会社 | 2022-02-01 | — | — | CN | disclosed |
| US-10676369-B2 | Method for producing AEI zeolite | TOSOH CORPORATION (JP) | 2020-06-09 | — | — | US | disclosed |
| EP-3336060-B1 | METHOD FOR PRODUCING AEI ZEOLITE | TOSOH CORP (JP) | 2020-01-29 | — | — | EP | disclosed |
| US-10513439-B2 | Method for producing AEI zeolite | TOSOH CORPORATION (JP) | 2019-12-24 | — | — | US | disclosed |
| US-20190337813-A1 | METHOD FOR PRODUCING AEI ZEOLITE | TOSOH CORPORATION (JP) | 2019-11-07 | — | — | US | disclosed |
| EP-3336060-A1 | METHOD FOR PRODUCING AEI ZEOLITE | Tosoh Corporation (JP) | 2018-06-20 | — | — | EP | disclosed |
| EP-1951192-B1 | Cosmetic or personal care composition comprising a polymer comprising oxazolidone groups | DSM IP ASSETS BV (NL) | 2013-01-02 | — | — | EP | disclosed |
| US-8268298-B2 | Cosmetic or personal care composition comprising a polymer comprising oxazolidon groups | DSM IP ASSETS B.V. (NL) | 2012-09-18 | — | — | US | disclosed |
| US-20110268685-A1 | COSMETIC OR PERSONAL CARE COMPOSITION COMPRISING A POLYMER COMPRISING OXAZOLIDON GROUPS | DSM IP ASSETS B.V. | 2011-11-03 | — | — | US | disclosed |
| US-20080267898-A1 | Cosmetic or Personal Care Composition Comprising a Polymer Comprising Oxazolidon Groups | DSM IP ASSETS B.V. (NL) | 2008-10-30 | — | — | US | disclosed |
| EP-1951192-A1 | COSMETIC OR PERSONAL CARE COMPOSITION COMPRISING A POLYMER COMPRISING OXAZOLIDON GROUPS | DSMIP Assets B.V. (NL) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007060006-A1 | COSMETIC OR PERSONAL CARE COMPOSITION COMPRISING A POLYMER COMPRISING OXAZOLIDON GROUPS | DSM IP ASSETS B.V. (NL) | 2007-05-31 | — | — | WO | disclosed |
| US-5154841-A | Cyclizing a polyamine with a fatty acid, ester, acyl halide or anhydride, followed by catalytic esterification with fatty acid ester or glycerides; titanium or tin alkoxides, salts, halides or alkyl halide as catalysts | THE PROCTER & GAMBLE COMPANY (US) | 1992-10-13 | — | — | US | disclosed |
| EP-0375029-A2 | Process for preparing substituted imidazoline fabric conditioning compounds | THE PROCTER & GAMBLE COMPANY (US) | 1990-06-27 | — | — | EP | disclosed |
| US-4720568-A | Basic colorants | BASF AKTIENGESELLSCHAFT (DE) | 1988-01-19 | — | — | US | disclosed |
| US-4597912-A | Basic colorants | BASF AKTIENGESELLSCHAFT (DE) | 1986-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110268685-A1 | COSMETIC OR PERSONAL CARE COMPOSITION COMPRISING A POLYMER COMPRISING OXAZOLIDON GROUPS | POLR1C, MC3R, MC1R | KDM4E 2329/4885PMP22 1205/4885ATM 2992/4885 |
| US-20080267898-A1 | Cosmetic or Personal Care Composition Comprising a Polymer Comprising Oxazolidon Groups | POLR1C, MC3R, MC1R | KDM4E 2390/4885PMP22 1255/4885ATM 2999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.